SCHEMBL2912809

SCHEMBL2912809

CC(C)(C)OC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(F)cc1F

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.37
GSK3A P49840 3/20 0.37
CDK1 P06493 2/20 0.33
CCNB2 O95067 1/20 0.33
CCNB1 P14635 1/20 0.33
CCNB3 Q8WWL7 1/20 0.33
BTK Q06187 2/20 0.32
HDAC1 Q13547 2/20 0.32
HDAC2 Q92769 2/20 0.32
MET P08581 1/20 0.31
AXL P30530 1/20 0.31
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
NPC1 O15118 1/20 0.30
BRD4 O60885 1/20 0.30
MAPK14 Q16539 1/20 0.30
EIF4E P06730 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2911576 0.92 GSK3B (0.36) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904015 0.92 GSK3B (0.43) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910224 0.92 GSK3B (0.42) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2909502 0.92 GSK3B (0.35) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2914083 0.90 MET (0.35) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912304 0.89 GSK3B (0.38) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL1219461 0.86 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910220 0.84 GSK3B (0.39) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2909914 0.84 GSK3B (0.43) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2906814 0.84 ALOX5AP (0.36) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed